Acclarent, Inc., a business unit of Ethicon, Inc., is a medical device
company located in Menlo Park, CA. Its singular focus is improving patient
care in all...
Catheter-Related Blood Stream Infections (CRBSI) are the 10th leading
cause of death in the United States
BIOPATCH® Disk is the only dressing clinically proven for use
in reducing CRBSI...
Precision engineered to deliver SURGIFLO® Hemostatic Matrix
Lightweight design for optimal control and ease of use
Single expression can deliver nearly 5 times more SURGIFLO® than
the competitors¹
Disposable,...
Designed Specifically for Vascular Reconstruction Procedures
ETHICON™ OMNEX™ is a 100% synthetic sealant which forms a
strong, flexible, physical seal preventing leakage of blood along suture
lines in...
Complex Problem. Simple Solution.
EVICEL® Fibrin Sealant (Human), once thawed, is ready on-demand to
meet your critical bleeding challenges by working independently of your
patient’s clotting factors.
The first...
Experience the Human Alternative
EVITHROM® Thrombin, Topical (Human) the only ready to use1
all human thrombin
Time to hemostasis equivalent to bovine thrombin at 3, 6,
and 10 minutes,...
INSTAT® MCH
Microfibrillar Collagen Hemostat
Utilizing Collagen to Achieve Superior Hemostasis
Microfibrillar structure allows convenient control of the amount of
product and better coherence of collagen fibers
Applicable for irregularly...
Introducing SURGICEL® SNoW™ Absorbable Hemostat
43% FASTERTime to Hemostasis than SURGICEL® Original Hemostat¹
FOUR Proven Performers
The first and only absorbable hemostats proven bactericidal against a
broad range of...
ADAPTABILITY
Speed Handling Performance...SURGICEL® SNoW™ Absorbable Hemostat
43% Faster time to hemostasis than SURGICEL® Original Hemostat1
Enhanced conformability and adherence to the bleeding site compared to
SURGICEL® Original Hemostat2
Structured...
Stop your bleeding.Not your procedure.
SURGIFLO® Hemostatic Matrix Family provides a variety of hemostatic
flowable options to manage bleeding challenges.
Stops bleeding in 2 minutes or less when...
The #1 Gelatin Family of Products in the US
SURGIFOAM® Absorbable Gelatin Powder
Complete coverage, rapid hemostasis on rough or uneven
surfaces
Add thrombin or saline to achieve desired...
Ethicon synthetic absorbable sutures exhibit a range of different
characteristics and capabilities. From VICRYL RAPIDE* (polyglactin 910)
Suture for effective short-term wound support, to PDS* II (polydioxanone)
Suture...
BLAKE® Silicone Drains
The BLAKE® Drains are white, radiopaque silicone drains with 4
channels along the sides with a solid core center. The other components
consist of a...
DERMABOND ADVANCED™ Topical Skin Adhesive
Wound Strength and Protection
DERMABOND ADVANCED™ provides a secure wound closure and a protective
microbial barrier over the wound.1
DERMABOND ADVANCED™ enhances wound closure...
DERMABOND™ PRINEO™ Skin Closure System
Supports wound with strength equivalent to 3-0 sutures1
Demonstrates equivalent wound healing and cosmesis compared to
original DERMABOND® Topical Skin Adhesive at 30...
Physiologically designed to complement your patient's every Twist and
Turn.1-5
Handling Characteristics
The handling characteristics of ETHICON PHYSIOMESH™ deliver
outstanding ease of use.5
Anatomy of abdominal wall can be viewed...
Unique, absorbable "strap" design uses 2 points of fixation to
straddle mesh pores and fibers, including large-pore constructions.4
Straddling a mesh pore.
Straddling a mesh fiber.
Delivers secure mesh...
FlexHD® Acellular Hydrated Dermis, a matrix derived from human skin, is
available through a strategic alliance between Ethicon and the
Musculoskeletal Transplant Foundation (MTF). FlexHD® Acellular Hydrated
Dermis...
Ethicon Hernia Solutions is pleased to offer a complete line of mesh
products for hernia repair. Further details are provided on the individual
hernia repair product pages...
Ethicon Nonabsorbable Sutures
Nonabsorbable materials are used to suture tissues requiring long-term or
permanent support in which the product strength is critical. They are
classified as monofilament or...
GYNECARE GYNEMESH® PS
for Vaginal Wall Prolapse Surgical Treatment
GYNECARE GYNEMESH® PS is indicated for tissue reinforcement and
long-lasting stabilization of fascial structures of the pelvic floor in
vaginal...
GYNECARE INTERCEED® Absorbable Adhesion Barrier
Safely and effectively reduces the formation of adhesions in a range
of open gynecologic pelvic procedures1
Reduces adhesion formation by forming a continuous...
To order GYNECARE MORCELLEX™ Tissue Morcellator:
Contact your local Ethicon Women's Health & Urology Sales
Representative or call 1-800-255-2500. GYNECARE MORCELLEX™ Tissue
Morcellator delivers an optimal combination of...
GYNECARE PROLIFT+M™complements your surgical abilities and helps you
meet the demands of symptomatic pelvic organ prolapse.¹
Coverage
GYNECARE PROLIFT+M™ offers proven apical and
mid-vagina support²
GYNECARE PROLIFT+M™ also provides lateral...
GYNECARE PROLIFT®
Total, Anterior and Posterior Pelvic Floor Repair Systems
The GYNECARE PROLIFT® Total, Anterior and Posterior Pelvic Floor
Repair Systems are indicated for tissue reinforcement and...
To order GYNECARE PROSIMA™ Contact your local Ethicon Women's Health
& Urology Sales Representative or call 1-800-255-2500. Only GYNECARE
PROSIMA™ delivers a truly tension-free repair of pelvic...
GYNECARE THERMACHOICE® III Uterine Balloon Therapy System
GYNECARE THERMACHOICE® III Uterine Balloon Therapy System is a thermal
balloon ablation device intended to ablate the endometrial lining of...
Introducing the next evolution in treatment for stress urinary
incontinence
The retropubic sling with tactilefeedback for
enhanced control
Confidence that you can achieveconsistent results with
less mesh
Prescribing Information
Prescribing Information
From...
GYNECARE VERSAPOINT™ Bipolar Electrosurgery System
GYNECARE VERSAPOINT™ Bipolar Electrosurgery System is an innovative
instrument with the potential to transform the way operative hysteroscopy
is performed. This advanced technology...
GYNECARE PROLIFT® Pelvic Floor Repair System
combines a unique delivery system with a specifically designed mesh implant
to allow surgeons to treat symptomatic prolapse patients.
GYNECARE PROLIFT+M™ Pelvic...
EVICEL® Fibrin Sealant (Human), once thawed, is ready on-demand to meet your critical bleeding challenges by working independently of your patient’s clotting factors.
The first and only fibrin sealant approved for general hemostasis in surgery when control of bleeding by standard surgical techniques is ineffective or impractical.
Ready-to-use in less than 1 minute after thawing*¹,²
All-Human formulation – EVICEL® does not contain aprotinin or bovine derivatives¹ and does not expose patients to the risks associated with aprotinin³
Multiple, clog-resistant tip options – Standard 6 cm tip or 35 cm Rigid or 45 cm Flexible tip
Spray or drip application with all tips
* Thaws within 10 minutes at 37°C (and must not be kept at this temperature for longer than 10 minutes); within 1 hour at 20°C to 25°C (room temperature); or within 1 day at 2°C to 8°C (refrigerator). Once thawed, EVICEL® must not be refrozen. Once at room temperature, EVICEL® must not be refrigerated.
References
1.
Data on file, ETHICON, INC.
2.
Food and Drug Administration. Aprotinin Injection (marketed as Trasylol). Rockville, Md: Food and Drug Administration; December 15, 2006.
EVICEL® Fibrin Sealant (Human) is indicated as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.
Important Safety Information:
For topical use only. Do not inject directly into the circulatory system.
Not indicated for the treatment of severe or brisk arterial bleeding.
Do not use in individuals known to have anaphylactic or severe systemic reaction to human blood products.
Air or gas embolism has occurred with the use of spray devices employing pressure regulator to administer fibrin sealants. These events appear to be related to the use of the spray device at higher than recommended pressures and in close proximity to the surface of the tissue. Follow labeled application instructions regarding pressure range and distance when using a spray device and monitor patients for the possibility of air or gas embolism.
Because this product is made from human plasma it may carry a risk of transmitting infectious agents, such as viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent.
Anaphylactic reactions may occur.
Most common adverse events reported in clinical trials (≥5%) are bradycardia, nausea, hypokalemia, insomnia, hypotension, pyrexia, graft infection, vascular graft occlusion, oedema peripheral, constipation.
See sales representative for Full Prescribing Information
Distributed by: Johnson & Johnson Wound Management
P.O. Box 151, Somervile, NJ 08876-0151
USA
Manufactured by: OMRIX biopharmaceuticals Ltd.
MDA Blood Bank,
Sheba Hospital, Ramar-Gan
POB 888, Kiryat Ono 55000
ISRAEL
EVICEL® Fibrin Sealant (Human) is indicated as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.
Important Safety Information:
For topical use only. Do not inject directly into the circulatory system.
Not indicated for the treatment of severe or brisk arterial bleeding.
Do not use in individuals known to have anaphylactic or severe systemic reaction to human blood products.
Air or gas embolism has occurred with the use of spray devices employing pressure regulator to administer fibrin sealants. These events appear to be related to the use of the spray device at higher than recommended pressures and in close proximity to the surface of the tissue. Follow labeled application instructions regarding pressure range and distance when using a spray device and monitor patients for the possibility of air or gas embolism.
Because this product is made from human plasma it may carry a risk of transmitting infectious agents, such as viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent.
Anaphylactic reactions may occur.
Most common adverse events reported in clinical trials (≥5%) are bradycardia, nausea, hypokalemia, insomnia, hypotension, pyrexia, graft infection, vascular graft occlusion, oedema peripheral, constipation.
See sales representative for Full Prescribing Information
Distributed by: Johnson & Johnson Wound Management
P.O. Box 151, Somervile, NJ 08876-0151
USA
Manufactured by: OMRIX biopharmaceuticals Ltd.
MDA Blood Bank,
Sheba Hospital, Ramar-Gan
POB 888, Kiryat Ono 55000
ISRAEL
Additional Professional information about EVICEL® Fibrin Sealant (Human) can be found below.
EVICEL® Fibrin Sealant (Human) is indicated as an adjunct to hemostasis for use in patients undergoing surgery, when control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.
Important Safety Information:
For topical use only. Do not inject directly into the circulatory system.
Not indicated for the treatment of severe or brisk arterial bleeding.
Do not use in individuals known to have anaphylactic or severe systemic reaction to human blood products.
Air or gas embolism has occurred with the use of spray devices employing pressure regulator to administer fibrin sealants. These events appear to be related to the use of the spray device at higher than recommended pressures and in close proximity to the surface of the tissue. Follow labeled application instructions regarding pressure range and distance when using a spray device and monitor patients for the possibility of air or gas embolism.
Because this product is made from human plasma it may carry a risk of transmitting infectious agents, such as viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent.
Anaphylactic reactions may occur.
Most common adverse events reported in clinical trials (≥5%) are bradycardia, nausea, hypokalemia, insomnia, hypotension, pyrexia, graft infection, vascular graft occlusion, oedema peripheral, constipation.
See sales representative for Full Prescribing Information
Distributed by:
Johnson & Johnson Wound Management
P.O. Box 151, Somervile, NJ 08876-0151
USA
Manufactured by:
OMRIX biopharmaceuticals Ltd.
MDA Blood Bank,
Sheba Hospital, Ramar-Gan
POB 888, Kiryat Ono 55000
ISRAEL